Largest one day declines
The 50 largest one day percentage moves lower recorded at the latest close. The largest moves were M1RN34.SA at −6.1% and MRNA at −5.8%. By size, the list splits into 11 mega cap and 39 large cap listings.
Switch view
All stocks50 of 23,178 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1D return | 1Y return |
|---|---|---|---|---|---|
| M1RN34.SA | Moderna, Inc. | $63.51B | Large cap | −6.11% | +462.13% |
| MRNA | Moderna, Inc. | $59.75B | Large cap | −5.77% | +496.25% |
| JAZZ | Jazz Pharmaceuticals plc | $16.89B | Large cap | −4.20% | +100.35% |
| LLY | Eli Lilly and Company | $1.06T | Mega cap | −3.59% | +62.80% |
| BSX | Boston Scientific Corporation | $69.81B | Large cap | −3.39% | −54.50% |
| B1AX34.SA | Baxter International Inc. | $13.60B | Large cap | −3.38% | +3.61% |
| B1SX34.SA | Boston Scientific Corporation | $70.04B | Large cap | −3.08% | −89.24% |
| CORT | Corcept Therapeutics Incorporated | $12.95B | Large cap | −3.05% | +71.81% |
| NVO | Novo Nordisk A/S | $208.63B | Mega cap | −3.02% | −13.32% |
| REGN | Regeneron Pharmaceuticals, Inc. | $83.89B | Large cap | −2.25% | +39.36% |
| MRK | Merck & Co., Inc. | $377.72B | Mega cap | −2.14% | +86.85% |
| RDOR3.SA | Rede D'Or São Luiz S.A. | $14.92B | Large cap | −2.13% | +1.37% |
| HALO | Halozyme Therapeutics, Inc. | $12.41B | Large cap | −2.07% | +46.30% |
| AZN | AstraZeneca PLC | $263.12B | Mega cap | −2.00% | +5.09% |
| B1NT34.SA | BioNTech SE | $28.32B | Large cap | −1.96% | +2.68% |
| GMAB | Genmab A/S | $21.42B | Large cap | −1.78% | +36.20% |
| ABT | Abbott Laboratories | $198.74B | Large cap | −1.75% | −11.83% |
| LILY34.SA | Eli Lilly and Company | $1.10T | Mega cap | −1.62% | +59.83% |
| PHG | Koninklijke Philips N.V. | $26.38B | Large cap | −1.60% | +1.27% |
| NVS | Novartis AG | $299.44B | Mega cap | −1.53% | +27.93% |
| BNTX | BioNTech SE | $28.28B | Large cap | −1.31% | +9.27% |
| SNY | Sanofi | $108.83B | Large cap | −1.30% | −4.33% |
| BBIO | BridgeBio Pharma, Inc. | $15.52B | Large cap | −1.28% | +60.05% |
| GSK | GSK plc | $104.29B | Large cap | −1.23% | +32.23% |
| INCY | Incyte Corporation | $25.97B | Large cap | −1.23% | +51.01% |
| ABVX | ABIVAX Société Anonyme | $10.17B | Large cap | −1.20% | +46.70% |
| JNJ | Johnson & Johnson | $658.24B | Mega cap | −1.15% | +55.40% |
| I1DX34.SA | IDEXX Laboratories, Inc. | $44.35B | Large cap | −1.11% | −17.31% |
| ABBV | AbbVie Inc. | $469.68B | Mega cap | −1.09% | +29.36% |
| EXEL | Exelixis, Inc. | $14.05B | Large cap | −1.09% | +45.68% |
| ASND | Ascendis Pharma A/S | $16.41B | Large cap | −1.08% | +29.66% |
| VRTX | Vertex Pharmaceuticals Incorporated | $138.63B | Large cap | −1.01% | +40.66% |
| JNJB34.SA | Johnson & Johnson | $658.09B | Mega cap | −0.98% | +47.82% |
| RDY | Dr. Reddy's Laboratories Limited | $10.18B | Large cap | −0.97% | −14.19% |
| ALC | Alcon Inc. | $35.13B | Large cap | −0.95% | −10.24% |
| PFE | Pfizer Inc. | $161.30B | Large cap | −0.95% | +18.72% |
| MCK | McKesson Corporation | $104.54B | Large cap | −0.93% | +31.57% |
| ABTT34.SA | Abbott Laboratories | $199.23B | Large cap | −0.90% | −16.35% |
| A1ZN34.SA | AstraZeneca PLC | $258.63B | Mega cap | −0.86% | +0.13% |
| KYMR | Kymera Therapeutics, Inc. | $10.53B | Large cap | −0.86% | +197.09% |
| CRL | Charles River Laboratories International, Inc. | $14.09B | Large cap | −0.85% | +81.27% |
| GEHC | GE HealthCare Technologies Inc. | $33.35B | Large cap | −0.81% | −1.15% |
| BMRN | BioMarin Pharmaceutical Inc. | $12.70B | Large cap | −0.77% | +11.85% |
| RGEN | Repligen Corporation | $10.25B | Large cap | −0.77% | +51.67% |
| VEEV | Veeva Systems Inc. | $39.78B | Large cap | −0.76% | −16.58% |
| N1VO34.SA | Novo Nordisk A/S | $208.90B | Mega cap | −0.75% | −17.86% |
| TAK | Takeda Pharmaceutical Company Limited | $58.60B | Large cap | −0.65% | +22.68% |
| REGN34.SA | Regeneron Pharmaceuticals, Inc. | $85.16B | Large cap | −0.59% | +33.80% |
| LH | Labcorp Holdings Inc. | $27.39B | Large cap | −0.58% | +21.14% |
| BMY | Bristol-Myers Squibb Company | $138.03B | Large cap | −0.52% | +47.01% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.
Micro and small cap listings are left out, so the list describes the market rather than thin trading, as are moves beyond 1,000% in a session, which are corporate actions the price series has not been restated for. This is a description of one day of price movement, nothing more. It says nothing about any company behind it.